Prostaglandin E2 and vascular endothelial growth factor A mediate angiogenesis of human ovarian follicular endothelial cells

Human Reproduction

Volumn 31, Issue 2, 2016, Pages 436-444

  Trau, Heidi A ^a   Brännström, Mats ^b   Curry, Thomas E ^c   Duffy, Diane M ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Endothelial cell; Follicle; Ovary; Ovulation; PGE2 receptor; Prostaglandin; Vascular endothelial growth factor; VEGF receptor

Indexed keywords

KI 67 ANTIGEN; PROSTAGLANDIN E2; RECOMBINANT CHORIONIC GONADOTROPIN; VASCULOTROPIN A; CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE;

ADULT; ANGIOGENESIS; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL MIGRATION; CELL PROLIFERATION; FEMALE; GRANULOSA CELL; HUMAN; HUMAN OVARIAN MICROVASCULAR ENDOTHELIAL CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INSTRUMENT STERILIZATION; LAPAROSCOPIC STERILIZATION; LAPAROSCOPIC SURGERY; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; OOCYTE DONATION; OVARY FOLLICLE CELL; SPROUT; UMBILICAL VEIN ENDOTHELIAL CELL; CELL CULTURE; CELL MOTION; ENDOTHELIUM CELL; METABOLISM; OVARY FOLLICLE; PHYSIOLOGY; VASCULARIZATION;

ADULT; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHORIONIC GONADOTROPIN; DINOPROSTONE; ENDOTHELIAL CELLS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUTEINIZING HORMONE; NEOVASCULARIZATION, PHYSIOLOGIC; OVARIAN FOLLICLE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84959892704     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev320     Document Type: Article

References (42)

1. Acosta TJ, Miyamoto A. Vascular control of ovarian function: ovulation, corpus luteum formation and regression. Anim Reprod Sci 2004;82-83: 127-140.
2. Arslan M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S. Controlled ovarian hyperstimulation protocols for in vitro fertilization: Two decades of experience after the birth of Elizabeth Carr. Fertil Steril 2005;84:555-569.
3. Bellik L, Vinci MC, Filippi S, Ledda F, Parenti A. Intracellular pathways triggered by the selective Flt-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia. Br J Pharmacol 2005;146: 568-575.
4. Bernatchez PN, Soker S, Sirois MG. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J Biol Chem 1999;274:31047-31054.
5. Bohgaki M, Kitaguchi H. Conversion of cultured monocytes/macrophages into endothelial-like cells through direct contact with endothelial cells. Int J Hematol 2007;86:42-48.
6. Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 2004; 36:1187-1205.
7. Buharalioglu CK, Song CY, Yaghini FA, Ghafoor HUB, Motiwala M, Adris T, Estes AM, Malik KU. Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation. Am J Physiol Heart Circ Physiol 2011;301:H1043-H1055.
8. Christenson LK, Stouffer RL. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre-and periovulatory follicles. J Clin Endocrinol Metab 1997;82:2135-2142.
9. Corner GW. Development, organization, and breakdown of the corpus luteum in the rhesus monkey. Contrib Embryol Carnegie Inst 1945; 31:117-146.
10. Delgado-Rosas F, Gaytan M, Morales C, Gomez R, Gaytan F. Superficial ovarian cortex vascularization is inversely related to the follicle reserve in normal cycling ovaries and is increased in polycystic ovary syndrome. Hum Reprod 2009;24:1142-1151.
11. deVries C, Escobedo JA, Ueno H, Houck KA, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-991.
12. Duffy DM, Stouffer RL. The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle. Mol Hum Reprod 2001;7:731-739.
13. Duffy DM, Stouffer RL. Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys. Hum Reprod 2002;17:2825-2831.
14. Endo A, Fukuhara S, Masuda M, Ohmori T, Mochizuki N. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF. J Recept Signal Transduct Res 2003;23:239-254.
15. Fraser HM, Duncan WC. Vascular morphogenesis in the primate ovary. Angiogenesis 2005;8:101-116.
16. Gillies PJ, Bray LJ, Richardson NA, Chirila TV, Harkin DG. Isolation of microvascular endothelial cells from cadaveric corneal limbus. Exp Eye Res 2015;131:20-28.
17. Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertil Steril 2008;89:922-926.
18. Hansen-Smith FM. Capillary network patterning during angiogenesis. Clin Exp Pharmacol Physiol 2000;27:830-835.
19. Hazzard TM, Molskness TA, Chaffin CL, Stouffer RL. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol Hum Reprod 1999;5:1115-1121.
20. Hazzard TM, Xu F, Stouffer RL. Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys. Biol Reprod 2002; 67:1305-1312.
21. Herbert SP, Stainier DYR. Molecular control of endothelial cell behaviour during blood vesselmorphogenesis. Nat RevMol Cell Biol 2011;12:551-564.
22. Herve MA, Buteau-Lozano H, Mourah S, Calvo F, Perrot-Applanat M. VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA. Exp Cell Res 2005;309:24-31.
23. Jeremy JY, Okonofua FE, Thomas M, Wojdyla J, Smith W, Craft IL, Dandona P. Oocyte maturity and human follicular fluid prostanoids, gonadotropins, and prolactin after administration of clomiphene and pergonal. J Clin Endocrinol Metab 1987;65:402-406.
24. Kamiyama M, Pozzi A, Yang L, DeBusk LM, Breyer RM, Lin PC. EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene 2006;25:7019-7028.
25. Koering MJ. Cyclic changes in ovarian morphology during the menstrual cycle in Macaca mulatta. Am J Anat 1969;126:73-101.
26. Markosyan N, Dozier BL, Lattanzio FA, Duffy DM. Primate granulosa cell response via prostaglandin E2 receptors increases late in the periovulatory interval. Biol Reprod 2006;75:868-876.
27. Miao H-Q, Hu K, Jimenez X, Navarro E, Zhang H, Lu D, Ludwig DL, Balderes P, Zhu Z. Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2. Biochem Biophys Res Commun 2006;345:438-445.
28. Narumiya S, Sugimoto T, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79:1193-1226.
29. Nieminen T, Toivanen PI, Ritanen N, Heikura T, Jauhiainen S, Airenne KJ, Alitalo K, Marjomaki V, Herttuala SY. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Biochim Biophys Acta 2014;1840:454-463.
30. Nishi J, Minamino T, Miyauchi H, Nojima A, Tateno K, Okada S, Orimo M, Moriya J, Fong G, Sunagawa K et al. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt. Circ Res 2008;103:261-268.
31. Ogawa S, Inoue S, Watanabe T, Hiroi H, Orimo A, Hosoi T, Ouchi Y, Muramatsu M. The complete primary structure of human estrogen receptor b (hERb) and its heterodimerization with ER a in vivo and in vitro. Biochem Biophys Res Commun 1998;243:122-126.
32. Rao R, Redha R, Macias-Perez I, Su Y, Hao C, Zent R, Breyer RM, Pozzi A. Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J Biol Chem2007;282:16959-16968.
33. Ratcliffe KE, Anthony FW, Richardson MC, Stones RW. Morphology and functional characteristics of human ovarian microvascular endothelium. Hum Reprod 1999;14:1549-1554.
34. Rosewell KL, Al-Alem LF, Zakerkish F, McCord L, Akin JW, Chaffin CL, Brannstrom M, Curry TEJ. Induction of proteinases in the human preovulatory follicle of the menstrual cycle by human chorionic gonadotropin. Fertil Steril 2014;103:826-833.
35. Sakurai T, Suzuki K, Yoshie M, Hashimoto K, Tachikawa E, Tamura K. Stimulation of tube formation mediated through the prostaglandin EP2 receptor in rat luteal endothelial cells. J Endocrinol 2011;209:33-43.
36. Scotti L, Abramovich D, Pascuali N, Irusta G, Meresman G, Tesone M, Paborell F. Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome. J Steroid Biochem Mol Biol 2014; 144:392-401.
37. Terman BI, Vermazen MD, Carrion ME, Dimitrov D, Armellino DC, Cospodarowicz D, Bohlem P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992;34:1578-1586.
38. Trau HA, Davis JS, Duffy DM. Angiogenesis in the primate ovulatory follicle is stimulated by luteinizing hormone via prostaglandin E2. Biol Reprod 2015; 92:15.
39. Weick RF, Dierschke DJ, Karsch FJ, Butler WR, Hotchkiss J, Knobil E. Periovulatory time courses of circulating gonadotropic and ovarian hormones in the rhesus monkey. Endocrinology 1973;93:1140-1147.
40. Wissing ML, Kristensen SG, Anderson CY, Mikkelsen AL, Host T, Borup R, Grondahl ML. Identification of new ovulation-related genes in humans by comparing the transcriptome of granulosa cells before and after ovulation triggering in the same controlled ovarian stimulation cycle. Hum Reprod 2014;29:997-1010.
41. Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM. Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor trap R1R2. Endocrinology 2002;143:2797-2807.
42. Zhang Y, Daaka Y. PGE2 promotes angiogenesis through EP4 and PKA Cg pathway. Blood 2011;118:5355-5364.